A. Templeton, M. Mcnamara, and B. ?eruga, Prognostic role of neutrophil-tolymphocyte ratio in solid tumors: a systematic review and meta-analysis, J. Natl. Cancer Inst, vol.106, p.124, 2014.
DOI : 10.1093/jnci/dju124

S. R. Walsh, E. J. Cook, and F. Goulder, Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer, Journal of Surgical Oncology, vol.23, issue.3, pp.181-184, 2005.
DOI : 10.1097/00000421-200006000-00011

M. Kang, S. Go, and H. Song, The prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancer, British Journal of Cancer, vol.17, issue.3, pp.452-460, 2014.
DOI : 10.1159/000127412

K. Atila, N. Arslan, and S. Derici, Neutrophil-to-lymphocyte ratio: could it be used in the clinic as prognostic marker for gastrointestinal stromal tumor? Hepatogastroenterology, pp.1649-1653, 2014.

T. Xue, L. Zhang, and X. Xie, Prognostic Significance of the Neutrophil-to-Lymphocyte Ratio in Primary Liver Cancer: A Meta-Analysis, PLoS ONE, vol.14, issue.7, p.96072, 2014.
DOI : 10.1371/journal.pone.0096072.s007

H. Cho, H. Hur, and S. Kim, Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment, Cancer Immunology, Immunotherapy, vol.23, issue.25, pp.15-23, 2008.
DOI : 10.1164/ajrccm.159.3.9805087

H. Luo, Y. Chen, and Y. Chuang, Subclassification of upper urinary tract urothelial carcinoma by the neutrophil-to-lymphocyte ratio (NLR) improves prediction of oncological outcome, BJU International, vol.121, issue.5b, pp.144-149, 2014.
DOI : 10.1111/j.1365-2567.2007.02587.x

Y. Luo, D. She, and H. Xiong, Pretreatment Neutrophil to Lymphocyte Ratio as a Prognostic Predictor of Urologic Tumors, Medicine, vol.94, issue.40, p.1670, 2015.
DOI : 10.1097/MD.0000000000001670

URL : http://doi.org/10.1097/md.0000000000001670

B. Ljungberg, K. Bensalah, and S. Canfield, EAU Guidelines on Renal Cell Carcinoma: 2014 Update, European Urology, vol.67, issue.5, pp.913-924, 2015.
DOI : 10.1016/j.eururo.2015.01.005

URL : https://hal.archives-ouvertes.fr/hal-01260564

D. Heng, W. Xie, and M. Regan, Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor???Targeted Agents: Results From a Large, Multicenter Study, Journal of Clinical Oncology, vol.27, issue.34, pp.5794-5799, 2009.
DOI : 10.1200/JCO.2008.21.4809

N. Grivas, V. Kafarakis, and I. Tsimaris, Clinico-pathological prognostic factors of renal cell carcinoma: A 15-year review from a single center in Greece, Urology Annals, vol.6, issue.2, pp.116-121, 2014.
DOI : 10.4103/0974-7796.130552

M. De-martino, A. Pantuck, and S. Hofbauer, Prognostic Impact of Preoperative Neutrophil-to-Lymphocyte Ratio in Localized Nonclear Cell Renal Cell Carcinoma, The Journal of Urology, vol.190, issue.6, pp.1999-2004, 2013.
DOI : 10.1016/j.juro.2013.06.082

Y. Ohno, J. Nakashima, and M. Ohori, Followup of Neutrophil-to-Lymphocyte Ratio and Recurrence of Clear Cell Renal Cell Carcinoma, The Journal of Urology, vol.187, issue.2, pp.411-417, 2012.
DOI : 10.1016/j.juro.2011.10.026

B. Cetin, V. Berk, and M. Kaplan, Is the Pretreatment Neutrophil to Lymphocyte Ratio an Important Prognostic Parameter in Patients with Metastatic Renal Cell Carcinoma?, Clinical Genitourinary Cancer, vol.11, issue.2, pp.141-148, 2013.
DOI : 10.1016/j.clgc.2012.09.001

P. Fox, M. Hudson, and C. Brown, Markers of systemic inflammation predict survival in patients with advanced renal cell cancer, British Journal of Cancer, vol.102, issue.1, pp.147-153, 2013.
DOI : 10.1159/000127412

URL : http://www.nature.com/bjc/journal/v109/n1/pdf/bjc2013300a.pdf

Y. Ohno, J. Nakashima, and M. Ohori, Followup of Neutrophil-to-Lymphocyte Ratio and Recurrence of Clear Cell Renal Cell Carcinoma, The Journal of Urology, vol.187, issue.2, pp.411-417, 2012.
DOI : 10.1016/j.juro.2011.10.026

S. Hatakeyama, T. Yoneyama, and I. Hamano, Prognostic benefit of surgical management in renal cell carcinoma patients with thrombus extending to the renal vein and inferior vena cava: 17-year experience at a single center, BMC Urology, vol.59, issue.6, p.47, 2013.
DOI : 10.1016/j.eururo.2011.02.032

M. Santoni, D. Giorgi, U. Iacovelli, and R. , Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma, British Journal of Cancer, vol.109, issue.7, pp.1755-1759, 2013.
DOI : 10.1200/JCO.2006.08.3774

URL : http://www.nature.com/bjc/journal/v109/n7/pdf/bjc2013522a.pdf

K. Koo, K. Lee, and K. Cho, Comprehensive analysis and validation of contemporary survival prognosticators in Korean patients with metastatic renal cell carcinoma treated with targeted therapy: prognostic impact of pretreatment neutrophil-to-lymphocyte ratio, International Urology and Nephrology, vol.171, issue.6, 2016.
DOI : 10.1097/01.ju.0000110610.61545.ae